Table 1 |
||||
|
Demographic and clinical characteristics of the studied subjects |
||||
| group I (n = 35) |
group II (n = 73) |
group III (n = 95) |
||
|
|
||||
| gender |
males |
11 |
25 |
19 |
| females |
24 |
48 |
76 |
|
| age (years) |
mean |
47.4 |
59.4 |
59.5 |
| range |
22–74 |
32–78 |
24–74 |
|
| compounding medication (n) |
acetylsalicylic acid |
7 |
33 |
4 |
| statins |
0 |
11 |
7 |
|
| steroids |
0 |
16 |
3 |
|
| thyroxin |
0 |
5 |
13 |
|
Watala et al. Thrombosis Journal 2003 1:7 doi:10.1186/1477-9560-1-7 |
||||
